In vitro cytotoxicity analysis on patient-derived PBMCs to predict 6-mercaptopurine therapy response in children with acute lymphoblastic leukemia. IJBB [Internet]. 2024 May 15 [cited 2026 May 16];61(6):371-9. Available from: https://or.niscpr.res.in/index.php/IJBB/article/view/9285